Possible role of angiotensin-converting enzyme polymorphism on progression of hepatic fibrosis in chronic hepatitis C virus infection. [electronic resource]
- Transactions of the Royal Society of Tropical Medicine and Hygiene Jul 2011
- 396-400 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1878-3503
10.1016/j.trstmh.2011.03.005 doi
Adult Antiviral Agents--therapeutic use Disease Progression Female Genetic Predisposition to Disease--genetics Genotype Hepatitis C, Chronic--drug therapy Humans Interferon alpha-2 Interferon-alpha--therapeutic use Liver Cirrhosis--enzymology Male Peptidyl-Dipeptidase A--genetics Polyethylene Glycols--therapeutic use Polymerase Chain Reaction Polymorphism, Genetic Recombinant Proteins Ribavirin--therapeutic use